Skip to main content

Table 2 Deleterious mutations including frame-shift, nonsense and splice site deleterious mutations identified in Malaysian breast cancer patients

From: Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer

No.

 

Exon

Nucleotide change

AA change

Reported

Family (No.)

Ethnicity

1

BRCA1

2

180 delA

STOP 22

Novel

1

Indian

2

 

2

185 delAG

STOP 39

Ashkenazi Jews, others

1

Indian

3

 

2

185 insA

STOP 40

Caucasian, European

1

Chinese

4

 

8

589 delCT

STOP 157

Caucasian, Caribbean

1

Chinese

5

 

11

1100 delAT

STOP 328

Caucasian, Chinese [10, 16]

1

Chinese

6

 

11

1173 G>T

E352X

Caucasian

1

Indian

7

 

11

1323 G>T

E402X

Novel

1

Malay

8

 

11

3889 delAG

STOP1265

Various

1

Chinese

9

 

13

4377 C>T

Q1420X

Caucasian, African-American

1

Chinese

10

 

20

5370 C>T

R1751X

Various

1

Indian

11

  

IVS 3+1 G>T

 

Novel

1

Chinese

12

  

IVS 3+2 delT

 

Novel

1

Chinese

13

  

IVS 4-1G>C

 

Novel

1

Indian

14

  

IVS 5-12 A>G

 

Various

1

Chinese

1

BRCA2

3

490 delCT

STOP 99

Novel

2

Malay

2

 

10

1184 insA

STOP 326

Caucasian

1

Chinese

3

 

10

2001 del4

STOP 612

Caucasian

1

Chinese

4

 

11

2699 del6

STOP 824

Novel

1

Malay

5

 

11

2864 delCT

STOP 879

Novel

1

Chinese

6

 

11

4265 delCT

STOP 1350

Filipino

1

Malay

7

 

11

6195 insA

STOP 2002

Novel

1

Malay

8

 

11

6553 delGT

STOP 2109

Novel

1

Chinese

9

 

11

6901 delA

STOP 2228

Novel

1

Chinese

10

 

11

6943 G>T

E2239X

Novel

1

Chinese

11

 

22

9097 C>T

Q2957X

Novel

1

Indian

12

 

23

9326 insA

STOP 3042

Various

1

Chinese

13

  

IVS 17+1 G>A

 

Caucasian

1

Chinese